See more : RocketFuel Blockchain, Inc. (RKFL) Income Statement Analysis – Financial Results
Complete financial analysis of CareCloud, Inc. (MTBC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CareCloud, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Huber+Suhner AG (HUBN.SW) Income Statement Analysis – Financial Results
- Bullfrog AI Holdings, Inc. Warrants (BFRGW) Income Statement Analysis – Financial Results
- Bank of Montreal (BMO-PF.TO) Income Statement Analysis – Financial Results
- Basic Energy Services, Inc. (BASX) Income Statement Analysis – Financial Results
- Bryton Inc. (7558.TWO) Income Statement Analysis – Financial Results
CareCloud, Inc. (MTBC)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.carecloud.com
About CareCloud, Inc.
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Practice Management. The company's Software-as-a-Service platform includes revenue cycle management, practice management, electronic health record, business intelligence, telehealth, and patient experience management solutions, as well as complementary software tools and business services for medical groups and health systems. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 117.06M | 138.83M | 139.60M | 105.12M | 64.44M | 50.55M | 31.81M | 24.49M | 23.08M | 18.30M | 10.47M | 10.02M | 10.09M |
Cost of Revenue | 70.82M | 84.43M | 86.92M | 64.82M | 41.19M | 31.25M | 17.68M | 13.42M | 11.63M | 10.64M | 4.27M | 4.26M | 4.51M |
Gross Profit | 46.24M | 54.39M | 52.68M | 40.30M | 23.25M | 19.29M | 14.13M | 11.08M | 11.45M | 7.67M | 6.20M | 5.76M | 5.58M |
Gross Profit Ratio | 39.50% | 39.18% | 37.74% | 38.34% | 36.08% | 38.17% | 44.42% | 45.22% | 49.61% | 41.89% | 59.20% | 57.50% | 55.33% |
Research & Development | 4.74M | 4.40M | 4.41M | 9.31M | 870.78K | 1.03M | 1.08M | 902.19K | 659.18K | 531.68K | 386.11K | 396.43K | 410.13K |
General & Administrative | 21.46M | 23.82M | 24.27M | 22.81M | 17.91M | 16.26M | 11.74M | 12.46M | 11.97M | 9.94M | 4.74M | 4.40M | 3.83M |
Selling & Marketing | 9.65M | 9.79M | 8.79M | 6.58M | 1.52M | 1.61M | 1.11M | 1.22M | 467.45K | 253.28K | 248.98K | 266.41K | 197.59K |
SG&A | 31.11M | 33.61M | 33.06M | 29.39M | 19.43M | 17.88M | 12.84M | 13.68M | 12.44M | 10.20M | 4.99M | 4.66M | 4.03M |
Other Expenses | 57.51M | 11.73M | 12.20M | 9.91M | 3.01M | 59.53K | 83.57K | -53.28K | 26.95K | -134.72K | 30.23K | 15.12K | 46.53K |
Operating Expenses | 93.36M | 49.73M | 49.66M | 48.61M | 23.31M | 21.76M | 18.23M | 19.69M | 17.69M | 13.52M | 6.33M | 5.74M | 4.99M |
Cost & Expenses | 164.17M | 134.17M | 136.58M | 113.43M | 64.50M | 53.01M | 35.91M | 33.11M | 29.32M | 24.16M | 10.60M | 10.00M | 9.49M |
Interest Income | 154.00K | 41.00K | 15.00K | 42.00K | 262.00K | 100.79K | 16.94K | 36.41K | 26.80K | 26.61K | 23.93K | 23.38K | 47.70K |
Interest Expense | 1.19M | 405.00K | 455.00K | 488.00K | 382.67K | 351.17K | 1.32M | 682.08K | 288.41K | 183.47K | 160.07K | 97.03K | 63.61K |
Depreciation & Amortization | 16.55M | 15.01M | 15.77M | 12.79M | 4.89M | 2.85M | 4.30M | 5.11M | 4.60M | 2.79M | 948.53K | 678.73K | 545.57K |
EBITDA | -31.29M | 21.03M | 19.22M | 4.57M | 3.13M | 909.13K | 126.81K | -2.81M | 337.42K | -1.36M | 1.10M | 892.75K | 1.32M |
EBITDA Ratio | -26.73% | 14.17% | 11.18% | 1.78% | 4.11% | 1.20% | 0.96% | -14.39% | -6.90% | -17.32% | 8.36% | 7.38% | 12.26% |
Operating Income | -47.12M | 4.06M | 3.53M | -8.26M | -421.10K | -2.54M | -4.52M | -7.90M | -4.46M | -4.04M | -127.52K | 22.02K | 597.06K |
Operating Income Ratio | -40.25% | 2.93% | 2.53% | -7.86% | -0.65% | -5.02% | -14.22% | -32.26% | -19.32% | -22.08% | -1.22% | 0.22% | 5.92% |
Total Other Income/Expenses | -1.92M | -1.00M | -536.00K | -439.00K | -746.02K | 243.95K | -975.19K | -698.95K | -91.33K | -291.58K | 94.01K | -31.30K | 116.67K |
Income Before Tax | -49.04M | 5.61M | 2.99M | -8.71M | -679.02K | -2.30M | -5.50M | -8.60M | -4.55M | -4.33M | -33.51K | 116.99K | 713.73K |
Income Before Tax Ratio | -41.89% | 4.04% | 2.14% | -8.29% | -1.05% | -4.54% | -17.28% | -35.11% | -19.71% | -23.67% | -0.32% | 1.17% | 7.07% |
Income Tax Expense | -364.00K | 177.00K | 157.00K | 103.00K | 192.78K | -157.39K | 67.81K | 196.80K | 137.79K | 176.53K | 144.49K | -4.00 | 243.84K |
Net Income | -48.67M | 5.43M | 2.84M | -8.81M | -871.80K | -2.14M | -5.57M | -8.80M | -4.69M | -4.51M | -178.00K | 117.00K | 469.90K |
Net Income Ratio | -41.58% | 3.91% | 2.03% | -8.38% | -1.35% | -4.23% | -17.49% | -35.91% | -20.31% | -24.64% | -1.70% | 1.17% | 4.66% |
EPS | -4.11 | 0.36 | 0.20 | -0.70 | -0.07 | -0.18 | -0.51 | -0.88 | -0.48 | -0.64 | -0.02 | 0.01 | 0.04 |
EPS Diluted | -4.11 | 0.36 | 0.20 | -0.70 | -0.07 | -0.18 | -0.51 | -0.88 | -0.48 | -0.64 | -0.02 | 0.01 | 0.04 |
Weighted Avg Shares Out | 15.67M | 15.11M | 14.54M | 12.68M | 12.09M | 11.72M | 11.01M | 10.04M | 9.73M | 7.08M | 10.98M | 10.98M | 10.98M |
Weighted Avg Shares Out (Dil) | 15.67M | 15.11M | 14.54M | 12.68M | 12.09M | 11.72M | 11.01M | 10.04M | 9.73M | 7.08M | 10.98M | 10.98M | 10.98M |
Fast-paced Momentum Stock CareCloud (CCLD) Is Still Trading at a Bargain
Why Fast-paced Mover CareCloud (CCLD) Is a Great Choice for Value Investors
CareCloud, Inc. (CCLD) Q2 2024 Earnings Call Transcript
CareCloud, Inc. (CCLD) Q2 Earnings and Revenues Beat Estimates
CareCloud To Announce Second-Quarter 2024 Results on August 13, 2024
Voting on CareCloud's Series A Proxy Continues with 82% of Early Proxies Favoring the Proposal
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
CareCloud Proposes Amendment to the Terms of its Series A Preferred Stock
Is CareCloud (CCLD) Stock Outpacing Its Medical Peers This Year?
Are Investors Undervaluing CareCloud (CCLD) Right Now?
Source: https://incomestatements.info
Category: Stock Reports